loginLogin phone+44 203 371 1100

Ligand Pharmaceuticals Incorporated

Credit Sector:- Health Care

Country:- United States

Bond Document:- https://www.bondpdf.com

In order to view the complete data, please login here

List of Corporate Actions

Announcement Date CA Type CA Impact CA Event ISIN
10-Oct-2018 Acquisition Acquired Name Vernalis PLC US00214WAE12
Ligand Pharmaceuticals Incorporated today announced that it has acquired Vernalis PLC.
09-Aug-2018 Propose Acquisition Target Name Vernalis PLC US00214WAE12
Ligand Pharmaceuticals Incorporated announced today that it intends to acquire Vernalis PLC.
22-May-2018 New Bond - - US53220KAE82
Ligand Pharmaceuticals Incorporated has issued USD 650MM, 0.750% fixed rate bond due 15-May-2023.
15-May-2019 New Bond - - US53220KAF57
Ligand Pharmaceuticals Incorporated has issued USD 750MM, Fixed rate Bond due 15-May-2023.
23-Jul-2019 Propose Acquisition Target Name AB Initio Biotherapeutics, Inc. US00214WAE12
Ligand Pharmaceuticals Incorporated announced today that it intends to acquire AB Initio Biotherapeutics, Inc.

Login to view more details

FactEntry

All of the financial data available on this page is sourced from FactEntry.